Non-Oral Benzodiazepine Combination Feasible for Seizures in Patients With Gliomas
the ONA take:
It is feasible to treat seizures with a combination of non-oral benzodiazepines in the end-of-life phase of patients with gliomas, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Because a rapid deterioration in neurological functioning may interfere with the oral intake of antiepileptic drugs (AEDs) for patients with gliomas who are at the end of life, researchers sought to assess the feasibility of non-oral AED treatment in an outpatient setting.
Researchers enrolled 25 patients with gliomas who had a history of epilepsy and were no longer deemed appropriate candidates for further antitumor therapy. Caregivers were to administer prophylactic treatment with buccal clonazepam as soon as swallowing difficulties developed. Acute seizures were treated with intranasal midazolam.
Results showed that seizure control was achieved in all patients and none of the patients needed to be admitted to the hospital due to recurrent seizures.
The combination of AEDs “seems to provide an important level of comfort among caregivers to be able to manage seizures at home,” the authors concluded.
It is feasible to treat seizures with a combination of non-oral benzodiazepines in the end-of-life phase of patients with gliomas.
Johan A. F. Koekkoek Affiliated withDepartment of Neurology, VU University Medical Center Department of Neurology, Medical Center Haaglanden Department of Neurology, Leiden University Medical Center Email author , Martin J. B.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- ONS Partners with ASCO CancerLinQ to Launch CancerLinQ® Ambassadors Program
- Characteristics of Clinical Trials and Barriers to Patient Enrollment Identified
- Exercise Improves Coping While Undergoing Chemotherapy for Advanced GI Cancer
- Genetic Similarity to BRCA1/BRCA2 Mutations May Impact Treatment Options
- Evidenced-Based Radiation Treatment Tied to Cost Savings in Early Stage Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|